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Abstract
Introduction: Clostridium difficile infection (CDI) is an increasingly recognized nosocomial infection in Singapore.
Surveillance methods include laboratory reporting of Clostridium difficile toxin assays (CDTA) or use of International
Classification of Diseases, 9
th Revision (ICD-9) discharge code 008.45. Previous US studies showed good correlation between
CDTA and ICD-9 codes. However, the use of ICD-9 codes for CDI surveillance has not been validated in other healthcare
settings.
Methods: We compared CDI rates based on CDTA to ICD-9 codes for all discharges in 2007 from our hospital to determine
sensitivity and specificity of ICD-9 codes. Demographic and hospitalization data were analyzed to determine predictors for
missing ICD-9 codes.
Results: During 2007, there were 56,352 discharges. Of these, 268 tested CDTA-positive but only 133 were assigned the CDI
ICD-9 code. A total of 141 discharges had the ICD-9 code; 8 were CDTA-negative, the rest were CDTA-positive. Community-
acquired CDI accounted for only 3.2% of cases. The sensitivity and specificity of ICD-9 codes compared to CDTA were 49.6%
and 100% respectively. Concordance between CDTA and ICD-9 codes was 0.649 (p,.001). Comparing concordant patients
(CDTA+/ICD9+) to discordant patients (CDTA+/ICD92), concordant patients were more likely to be over 50 years of age (OR
3.49, 95% CI 1.66–7.34, p=.001) and have shorter time from admission to testing (OR 0.98, 95% CI 0.97–0.99, p=.009).
Discussion: Unlike previous studies in the US, ICD-9 codes substantially underestimate CDI in Singapore compared to
microbiological data. Older patients with shorter time to testing were less likely to have missing ICD-9 codes.
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Introduction
Clostridium difficile infection (CDI) is an emerging healthcare-
associated problem in Singapore. Among hospitalized patients in
our institution, CDI incidence has risen 4-fold from 1.49 cases per
10,000 patient-days in 2001 to 6.64 cases per 10,000 patient-days
in 2006 [1]. This increased incidence is comparable to that
reported by large hospitals in Canada [2], and mirrors the
increases seen in North America and Europe over the past decade.
However, national surveillance systems to track CDI rates are
relatively less well-developed. Currently, potential surveillance
methods include laboratory-based reporting of diagnostic assays
or administrative surveillance using International Classification
of Diseases, 9
th Revision (ICD-9) codes assigned to hospital
discharges. Although the primary role of ICD-9 codes is for
remuneration, easy accessibility, standardized format across
healthcare facilities and consistency over time make ICD-9 codes
attractive for surveillance purposes. Previous studies in the United
States demonstrated good correlation between toxin assay results
and ICD-9 codes, with sensitivity and specificity of ICD-9 codes
reported at 71–78% and .99% respectively compared to
microbiologic data [3–5]. A recent study by Zilberberg and
colleagues showed good agreement between pediatric CDI
hospitalization rates using administrative (ICD-9) coding from 2
separate databases [6]. However, use of ICD-9 codes for CDI
surveillance has not been validated in other healthcare settings
including Asia. In this study, we compared CDI rates based on
laboratory diagnostic testing to CDI diagnoses captured by ICD-9
codes for hospitalized patients to determine the sensitivity and
specificity of ICD-9 codes for use as CDI surveillance.
Methods
Ethics Statement: The institutional ethics review board for the
National Healthcare Group Domain Specific Review Board
(NHG DSRB) approved the study prior to initiation (approval
number DSRB E/09/008). A waiver of informed consent was
specifically requested and granted by the NHG DSRB because the
study methods utilized retrospective medical record review on
hospitalization records of patients who had been discharged over 2
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unlinked datasets and reported in anonymized aggregate form.
The study was conducted at Tan Tock Seng Hospital, a 1200-
bed public hospital in Singapore. All patients in 2007 with positive
Clostridium difficile toxin assay (CDTA) or with discharge summaries
containing the ICD-9 code of 008.45 for CDI were retrospectively
reviewed. Hospital laboratory testing of CDTA, for both Toxin
A and B using ELISA and Immunocard (both from Meridian
Bioscience, Inc., Cincinnati, OH, USA) was performed on
unformed stool samples based on clinical suspicion of CDI. An
in-house evaluation of the Immunocard method compared with
PCR method gave a sensitivity of 64%, specificity of 95%, positive
predictive value of 78% and negative predictive value of 90%
(unpublished data) which is comparable to reported literature [7].
Demographic and hospitalization data were extracted from
electronic medical records. The x
2 test and Fisher’s exact test
were used to compare categorical variables. Student’s t test and the
Mann-Whitney U test were used to compare continuous variables.
All statistical analyses were performed using Stata, version 9.0
(Stata Corp). Corresponding percentages, ORs, and 95% con-
fidence intervals are reported.
Results
Of 56,352 admissions to Tan Tock Seng Hospital in 2007,
2,212 (3.9%) patients had CDTA requested. Clostridium difficile
toxin assay were positive in 268 (12.1%) but only 133 were
assigned the ICD-9 code [Figure 1]. An ICD-9 code of 008.45 for
CDI was assigned to 141 discharges. Of these, 133 had CDTA-
positive and 8 had CDTA-negative results. Review of medical
records confirmed symptoms of diarrhea, abdominal pain or
cramping in all patients with positive CDTA or ICD-9 code.
The sensitivity of ICD-9 codes was 49.6% and the specificity
was 99.99%, using laboratory diagnosis as the reference standard.
Both positive and negative predictive values of the ICD-9 code
were excellent at 94.3% and 99.8% respectively. The CDI rate
was 2.50 per 1000 admissions based on ICD-9 codes, compared to
4.76 per 1000 admissions based on laboratory test reporting
[Figure 2]. Although CDI rate was under-estimated by use of
ICD-9 code, the time series graph showed fair correlation between
rates of CDTA and ICD-9 code with good concordance rate
(K=0.649; p,.001).
Length of hospitalization, admitting discipline, ethnic group,
and configuration of hospital beds (rooms with 1, 2, 4 or 6 beds)
were not significant factors for missing ICD-9 code [Table 1].
Comparing concordant patients with positive toxin assays and
ICD-9 codes (CDTA+/ICD9+) to discordant patients with
positive toxin assays but no ICD-9 codes (CDTA+/ICD92),
median age was significantly older in concordant patients (75 vs 69
years; p,.001) and median time from admission to positive stool
test collection was significantly shorter (8 vs 10 days; p=0.048)
[Table 1]. Concordant patients (CDTA+/ICD9+) were more
likely to be over 50 years of age (OR, 3.49; 95% CI, 1.66–7.34;
P=.001) and had a shorter time from admission to stool testing
(OR, 0.98; 95% CI, 0.97–0.99; P=.009) [Table 2]. Review of the
electronic medical record for the discordant cases (CDTA+/
ICD92) revealed 71 of the 135 cases (52.6%) had the diagnosis of
CDI discussed in the text of the discharge summaries, but were
inadvertently missed by the coders.
Among those who had a positive toxin assay, 62 (23%) had their
positive stool samples collected within 48 hours of admission. Of
these 62, only 2 (3.2%) had no public hospital admissions or
government outpatient clinic attendances within the preceding 12
weeks [8]. This suggests that true community-associated CDI
without any healthcare facility exposures remains uncommon at
this time.
Of the 8 patients who had a positive ICD-9 code but negative
CDTA (CDTA2/ICD9+), none had colonoscopy performed for
confirmatory histological or pathological diagnosis. However, 7
were considered to have CDI by their treating physicians and
received treatment for presumptive CDI.
Discussion
Rates of Clostridium difficile infection would be substantially
underestimated by ICD-9 codes compared to laboratory testing in
our setting. Sensitivity of ICD-9 codes is poor compared to
laboratory testing but specificity remains high. A substantial
reduction in sensitivity is attributable to coder interpretation of
medical records. More than half of the cases with missed ICD-9
Figure 1. Flowchart of Clostridium difficile diagnoses among all patients admitted in 2007 to Tan Tock Seng Hospital.
doi:10.1371/journal.pone.0015603.g001
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doi:10.1371/journal.pone.0015603.g002
Table 1. Factors associated with concordant Clostridium difficile diagnosis by positive Clostridium difficile toxin assay (CDTA+) and
ICD-9 code (ICD9+).
Univariate analysis
Variables
Group A
CDTA+ ICD92 (n=135)
Group B
CDTA+ ICD9+ (n=133) p value
Age, median years (range) 69 (16–98) 75 (21–101) 0.0007
Age .50 yrs, n (%) 102 (75.6) 122 (91.7) 0.0004
Male gender, n (%) 82 (60.7) 67 (50.4) 0.09
LOS, median days (range) 22 (1–689) 21 (2–190) 0.549
LOS .30 days, n (%) 59 (43.7) 55 (41.4) 0.697
Time from admission to positive stool collection, median days (range) 10 (0–452) 8 (0–70) 0.048
Admission day to test .30 days, n (%) 30 (22.2) 16 (12.0) 0.027
Test to Date of discharge, median days (range) 11 (0–331) 11 (1–131) 0.216
Surgical discipline, n (%) 12 (9.0) 18 (13.3) 0.263
Chinese, n (%) 100 (74.1) 101 (76.0) 0.724
Malay, n (%) 20 (14.8) 16 (12.0) 0.503
Indian, n (%) 11 (8.2) 12 (9.0) 0.798
Others, n (%) 4 (2.9) 4 (3.0) 0.983
C class, n (%) 81 (60.0) 74 (55.6) 0.469
B1 class, n (%) 4 (3.0) 9 (6.8) 0.147
B2 class, n (%) 43 (31.9) 46 (34.6) 0.635
A class, n (%) 7 (5.2) 4 (3.0) 0.369
B2 or C class (5–6 beds), n (%) 124 (91.9) 120 (90.2) 0.641
doi:10.1371/journal.pone.0015603.t001
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discharge summary, yet were not coded appropriately. Inclusion of
these records would increase sensitivity from 49.6% to 76%,
comparable to other published studies [3–5]. Training for coders
could improve sensitivity and make ICD-9 coding feasible as a
surveillance instrument for CDI. Although ICD9 coding system is
widely used and should be standardized, differences in institutional
structure and awareness of Clostridium difficile may influence coding
practices. Public hospitals in Singapore offer government-subsi-
dized healthcare with individual ‘‘co-payment’’ from compulsory
medical saving plans. It is possible that differences in payers and
billing methods could affect the rigor of medical coding if
compared to private hospitals or insurance-based healthcare
systems elsewhere. These findings suggest variations in sensitivity
that should be validated before use in surveillance.
Previous studies have shown variable sensitivities of ICD-9
codes depending on infection type, varying from 95% in central
nervous system infection [8] to as low as 5.9% in sepsis [9,10]. Use
of ICD-9 codes in Clostridium infection has moderate to superior
sensitivity of 71–78% compared to other infective conditions [3–
5], probably due to the well defined signs, symptoms and
diagnostic methods for a case definition [11].
Factors associated with concordant results were older age,
possibly due to increased awareness of multiple diagnoses related
to hospital admission. Shorter time between admission date and
ordering of CDTA may again increase likelihood of inclusion of
CDI in medical records and subsequent coding. Community-
associated CDI cases were rare, with the overwhelming majority
having had recent healthcare exposure in the preceding 12 weeks.
Electronic microbiology reporting appears to be a reliable
measure for surveillance purposes [12]. Using administrative data
did not identify a significant number of additional cases. One
advantage of laboratory reporting is the capture of outpatient cases
and cases from affiliated healthcare facilities such as rehabilita-
tion centers or nursing homes which may rely upon hospital
laboratories for diagnostic testing. An automated algorithm com-
bining microbiology, pharmacy and coding data has become the
case-finding method of choice at some institutions [13] although
this may have limited advantages compared to microbiology data
and incurs increased costs [14].
This study was limited to a single public hospital over a one-year
period and our findings may not necessarily apply to other
institutions within Singapore or elsewhere. This study on 2007
data may need to be repeated with data from other years in order
to determine if and how these findings might vary over time. With
C.difficile emerging as a public health threat in the past decade,
countries seeking to establish national surveillance for CDI may
choose administrative data as their surveillance instrument
because of relative accessibility, consistency between different
datasets and for longitudinal comparisons [6]. Our findings
underscore the importance of validating the use of administrative
data such as ICD-9 codes for tracking disease trends because
reliability from one geographic region or healthcare system may
not translate directly to others.
In conclusion, although good sensitivity and specificity were
found in US studies for CDI surveillance, exclusive use of ICD-9
codes would substantially underestimate CDI incidence in
Singapore. Laboratory reporting would provide a more accurate
measure of CDI incidence. Nevertheless, ICD-9 codes correlates
moderately well with laboratory reporting for disease trends, and
would remain a useful indicator for tracking CDI disease trends for
surveillance purposes.
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